Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 128 citations
Electronic publication date
October 25, 2006

View on Pubmed.gov 16973584 | View on doi.org 10.1128/JVI.005...

Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins.

Search for publications in this journal J Virol - 80(19):9798-810

Abstract

Foot-and-mouth disease virus (FMDV) can use a number of integrins as receptors to initiate infection. Attachment to the integrin is mediated by a highly conserved arginine-glycine-aspartic acid (RGD) tripeptide located on the GH loop of VP1. Other residues of this loop are also conserved and may contribute to integrin binding. In this study we have used a 17-mer peptide, whose sequence corresponds to the GH loop of VP1 of type O FMDV, as a competitor of integrin-mediated virus binding and infection. Alanine substitution through this peptide identified the leucines at the first and fourth positions following RGD (RGD+1 and RGD+4 sites) as key for inhibition of virus binding and infection mediated by alphavbeta6 or alphavbeta8 but not for inhibition of virus binding to alphavbeta3. We also show that FMDV peptides containing either methionine or arginine at the RGD+1 site, which reflects the natural sequence variation seen across the FMDV serotypes, are effective inhibitors for alphavbeta6. In contrast, although RGDM-containing peptides were effective for alphavbeta8, RGDR-containing peptides were not. These observations were confirmed by showing that a virus containing an RGDR motif uses alphavbeta8 less efficiently than alphavbeta6 as a receptor for infection. Finally, evidence is presented that shows alphavbeta3 to be a poor receptor for infection by type O FMDV. Taken together, our data suggest that the integrin binding loop of FMDV has most likely evolved for binding to alphavbeta6 with a higher affinity than to alphavbeta3 and alphavbeta8.

References

J Biol Chem. 1990 Jul 15;265(20):11502-7

J Gen Virol. 2005 Oct;86(Pt 10):2769-80

Acta Virol. 1991 Jan;35(1):90-3

Virology. 1993 Feb;192(2):568-77

Cited by 128 citations (total)

Journal Article Review

PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments.

Electronic publication date March 31, 2015

Search for publications in this journal Biomed Res Int

Roland Haubner [...] Olaf Prante et al.

Noninvasive determination of integrin expression has become an interesting approach in nuclear medicine. Since the discovery of the first 18F-labeled...

Journal Article Research Support, Non-U.S. Gov't

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Electronic publication date June 7, 2017

Search for publications in this journal Mol Ther

Lynsey M Whilding [...] John Maher et al.

Expression of the αvβ6 integrin is upregulated in several solid tumors. In contrast, physiologic expression of this epithelial-specific integrin is...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances